Location · McKinney, TX
Clinical trials in McKinney, TX
33 recruiting studies have a site in McKinney, and 0 of them accept healthy volunteers.
33 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- McKinney, TX + 27 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AstraZeneca
- Location
- McKinney, TX + 58 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- McKinney, TX + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Windward Bio
- Location
- McKinney, TX + 8 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Generate Biomedicines
- Location
- McKinney, TX + 35 other US sites
- Eligibility basics
- Ages 12–80
- RecruitingPhase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Location
- McKinney, TX + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Windward Bio
- Location
- McKinney, TX + 2 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- McKinney, TX + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Ionis Pharmaceuticals, Inc.
- Location
- McKinney, TX + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Biohaven Therapeutics Ltd.
- Location
- McKinney, TX + 52 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
argenx
- Location
- McKinney, TX + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Boehringer Ingelheim
- Location
- McKinney, TX + 78 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Regeneron Pharmaceuticals
- Location
- McKinney, TX + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- McKinney, TX + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
AstraZeneca
- Location
- McKinney, TX + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Regeneron Pharmaceuticals
- Location
- McKinney, TX + 55 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Eli Lilly and Company
- Location
- McKinney, TX + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Eli Lilly and Company
- Location
- McKinney, TX + 28 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Eli Lilly and Company
- Location
- McKinney, TX + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Kymera Therapeutics, Inc.
- Location
- McKinney, TX + 30 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
GlaxoSmithKline
- Location
- McKinney, TX + 36 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
MapLight Therapeutics
- Location
- McKinney, TX + 32 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Expedition Therapeutics, Inc
- Location
- McKinney, TX + 21 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 2
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Tonix Pharmaceuticals, Inc.
- Location
- McKinney, TX + 25 other US sites
- Eligibility basics
- Ages 18+